Detalhe da pesquisa
1.
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver.
Nature
; 626(7999): 635-642, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297127
2.
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.
Proc Natl Acad Sci U S A
; 119(32): e2119514119, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914158
3.
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.
Hepatology
; 77(3): 729-744, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302667
4.
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses.
J Hepatol
; 78(2): 376-389, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455783
5.
Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.
Hepatology
; 74(2): 776-796, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619771
6.
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Gastroenterology
; 159(2): 609-623, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275969
7.
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
Hepatology
; 69(4): 1768-1786, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561826
8.
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Hepatology
; 67(6): 2254-2270, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29171881
9.
Transketolase counteracts oxidative stress to drive cancer development.
Proc Natl Acad Sci U S A
; 113(6): E725-34, 2016 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26811478
10.
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
J Hepatol
; 67(4): 758-769, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28532996
11.
Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
Hepatology
; 64(3): 797-813, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27228567
12.
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
Hepatology
; 60(5): 1645-58, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048396
13.
Neutrophil-activating therapy for the treatment of cancer.
Cancer Cell
; 41(2): 356-372.e10, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706760
14.
Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development.
Sci Adv
; 9(18): eade5111, 2023 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146141
15.
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Hepatol Commun
; 6(1): 178-193, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558800
16.
Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer.
Nat Commun
; 13(1): 954, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35177645
17.
The Amot/integrin protein complex transmits mechanical forces required for vascular expansion.
Cell Rep
; 36(8): 109616, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433061
18.
Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer.
Cell Rep
; 34(4): 108676, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33503428
19.
Assessment of Stabilization and Activity of the HIFs Important for Hypoxia-Induced Signalling in Cancer Cells.
Methods Mol Biol
; 1928: 77-99, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30725452
20.
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer.
Oncogenesis
; 7(5): 44, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29799025